(Q33338688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

0 references

Tomas Navarro-Rodriguez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rejane Mattar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Fernando M Silva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jaime N Eisig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ana Cristina S Teixeira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ricardo C Barbuti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

29 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

8 January 2020

copyright license

start time

29 May 2008

1 reference

April 2022 Public Data File from Crossref

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Prevalence of Helicobacter pylori infection in children from an urban community in north-east Brazil and risk factors for infection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Review article: treatment of Helicobacter pylori infection and factors influencing eradication

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Pooled analysis of anti-Helicobacter pylori treatment regimens.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Patient factors affecting Helicobacter pylori eradication with triple therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Metronidazole-resistant Helicobacter pylori in a developing country.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Drug therapy for Helicobacter pylori infection: problems and pitfalls

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Helicobacter pylori: factors affecting eradication and recurrence

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-8-20

Seroprevalence and risk factors associated with Helicobacter pylori infection in blood donors in Salvador, Northeast-Brazil

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Determination of azithromycin in gastric biopsy samples.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

Azithromycin for the cure of Helicobacter pylori infection

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2438368

[Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection]

31 October 2018

1 reference

12 December 2020

Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection

1 reference

12 December 2020

[Trends of peptic ulcer mortality in São Paulo State (Brazil), 1970-1989]

1 reference

12 December 2020

Helicobacter pylori eradication in clinical practice: one-week low-dose triple therapy is preferable to classical bismuth based triple therapy

1 reference

12 December 2020

Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions

1 reference

12 December 2020

Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis

1 reference

12 December 2020

Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

1 reference

12 December 2020

Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease

1 reference

12 December 2020

[Second Brazilian Consensus Conference on Helicobacter pylori infection]

1 reference

12 December 2020

[Health care services utilization and access inequalities in the Sao Paulo Metropolitan Region]

1 reference

12 December 2020

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

12 December 2020

Gastric cancer in Brazil

1 reference

12 December 2020

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-8-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18510773%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

18510773

1 reference